ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,469.33
      0.00%
      US Tech 100
      19,179.22
      0.02%
      Dow Jones
      39,154.41
      0.11%
      Brent Oil
      84.875
      0.82%
      Bitcoin
      61,204.09
      -0.98%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Immunocore Holdings PLC (IMCR) Quote

      Immunocore Holdings PLC

      Immunocore Holdings PLC (IMCR)

      NASDAQ
      34.21
      -1.23
      ( -3.47% )
      Updated: 13:44:59
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      34.21
      Bid
      34.22
      Ask
      34.30
      Volume
      942,486
      33.89 Day's Range 35.405
      0.00 52 Week Range 0.00
      Market Cap
      1.652B
      Previous Close
      35.44
      Open
      35.01
      Last Trade
      11
      @
      34.255
      Last Trade Time
      13:45:03
      Financial Volume
      $ 32,327,454
      VWAP
      34.3002
      Average Volume (3m)
      -
      Shares Outstanding
      48,088,346
      Dividend Yield
      -
      PE Ratio
      -29.88
      Earnings Per Share (EPS)
      -1.15
      Revenue
      249.43M
      Net Profit
      -55.29M

      About Immunocore Holdings PLC

      Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority o... Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States. Show more

      Sector
      Noncomml Resh Organizations
      Industry
      Noncomml Resh Organizations
      Website
      www.immunocore.com
      Headquarters
      Oxfordshire, Gbr
      Founded
      1970
      Immunocore Holdings PLC is listed in the Noncomml Resh Organizations sector of the NASDAQ with ticker IMCR. The last closing price for Immunocore was $35.44. Over the last year, Immunocore shares have traded in a share price range of $ 0.00 to $ 0.00.

      Immunocore currently has 48,088,346 shares outstanding. The market capitalization of Immunocore is $1.65 billion. Immunocore has a price to earnings ratio (PE ratio) of -29.88.

      IMCR Latest News

      More News

      FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

      4 hours ago

      Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

      Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous...

      June 18 2024
      GlobeNewswire Inc.

      Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

      Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response Data were...

      June 01 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 31 2024
      Edgar (US Regulatory)

      Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

      Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 Monotherapy...

      May 31 2024
      GlobeNewswire Inc.

      Immunocore to present at the Jefferies Global Healthcare Conference

      Immunocore to present at the Jefferies Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 30 May 2024) Immunocore Holdings plc (Nasdaq: IMCR...

      May 30 2024
      GlobeNewswire Inc.

      Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

      Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with...

      May 29 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 28 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 28 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WENAANEW MEDICAL INC
      $ 3.91
      (136.97%)
      		79.33M
      OPTXSyntec Optics Holdings Inc
      $ 4.5812
      (94.94%)
      		31.34M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.47
      (77.36%)
      		546.62M
      CMAXCareMax Inc
      $ 3.281
      (72.68%)
      		7.01M
      AIEVThunder Power Holdings Inc
      $ 2.3585
      (37.12%)
      		29.17M
      CNSPCNS Pharmaceuticals Inc
      $ 1.77
      (-37.68%)
      		1.34M
      GRIGRI Bio Inc
      $ 1.87
      (-37.04%)
      		629.25k
      NUWENewellis Inc
      $ 0.14195
      (-34.83%)
      		9.78M
      LYELLyell Immunopharma Inc
      $ 1.345
      (-34.07%)
      		8.9M
      BJDXBluejay Diagnostics Inc
      $ 1.86
      (-32.36%)
      		2.02M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.47
      (77.36%)
      		546.62M
      NVDANVIDIA Corporation
      $ 123.855
      (-1.77%)
      		241.22M
      RIVNRivian Automotive Inc
      $ 14.3859
      (20.28%)
      		205.51M
      WENAANEW MEDICAL INC
      $ 3.91
      (136.97%)
      		79.33M
      SQQQProShares UltraPro Short QQQ
      $ 8.2305
      (-1.90%)
      		75.41M

      IMCR Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      IMCR over $30
      👍️0

      Your Recent History

      NASDAQ
      IMCR
      Immunocore
      LSE
      TJ59
      Cardif 22-1 28
      AMEX
      AEON
      AEON Biopharma
      Delayed Upgrade Clock